CEO Christophe Weber to retire from Takeda in June 2026 after 12 years; Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process ...

Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q1 2022 Earnings Conference Call July 30, 2021 6:00 AM ETCompany Participants. Christopher O'Reilly - Global Head, IR & Global Finance Christophe Weber ...

Takeda Pharmaceutical Company Limited (NYSE: ... CEO Christophe Weber on Q2 2022 Results - Earnings Call Transcript. Oct. 29, 2021 2:52 PM ET Takeda Pharmaceutical Company Limited ...

When Christophe Weber was appointed CEO of Takeda in 2014, he set out on a mission to transform the 240-year old Japanese pharmaceutical company into a major global player.

Takeda Pharmaceutical Co.’s shares might be trading at about half of their level before the $62 billion acquisition of Shire in 2018, ... Chief Executive Officer Christophe Weber said. ...

Takeda Warns New Drugs at Risk If Countries Push Deep Price ... “If you push too much you reach a point where you’ll impact the ability to invest in R&D and innovate,” Christophe Weber, ...

Takeda Pharmaceutical Company Limited (TKPYY) Proposed Acquisition of Shire PLC Group May 8, 2018 3:15 AM ET. Executives. Christophe Weber - President and CEO ...

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q1 2022 Results Conference Call July 28, 2022 6:00 AM ETCompany Participants. Ayako Iwamuro - IR Christophe Weber - President and CEO Andy Plump ...

Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q2 2021 Earnings Conference Call October 29, 2020 5:30 AM ETCompany Participants. Christopher O'Reilly - IR Christophe Weber - President, CEO ...

Takeda Pharmaceutical Company Limited. (NYSE:TAK) Q3 2022 Earnings Conference Call February 3, 2022 6:00 AM ETCorporate ParticipantsChristopher O’Reilly - ...

Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q3 2021 Earnings Conference Call February 4, 2021 6:00 AM ETCompany Participants. Christopher O'Reilly - Global Head, IR & Global Finance Christophe Weber ...

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2022 Earnings Conference Call May 11, 2022 6:00 AM ETCompany Participants. Ayako Iwamuro - IR Christophe Weber - CEO Andy Plump - R&D President ...